Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Prevention and treatment of cytomegalovirus infection in organ transplant recipients. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/hep.1840160202
10.1002/hep.1840160202 · External reference
Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts?
1992 · External reference
10.1001/jama.1989.03420240075030
10.1001/jama.1989.03420240075030 · External reference
10.1164/ajrccm/146.6.1419
10.1164/ajrccm/146.6.1419 · External reference
10.1056/nejm197804272981705
10.1056/nejm197804272981705 · External reference
Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
10.1111/j.1399-0012.1996.tb00433.x · 1966 · External reference
10.1016/s0002-9343(97)80021-6
10.1016/s0002-9343(97)80021-6 · External reference
10.1097/00007890-199706150-00010
10.1097/00007890-199706150-00010 · External reference
10.1086/514142
10.1086/514142 · External reference
10.7326/0003-4819-123-1-199507010-00002
10.7326/0003-4819-123-1-199507010-00002 · External reference
Cytomegalovirus infection in transplant recipients, the role of tumor necrosis factor.
10.1097/00007890-199409000-00007 · 1994 · External reference
Workshop on CMV disease; definitions, clinical severity scores, and new syndromes.
1995 · External reference
Unresolved reference
1993 · External reference
10.1056/nejm199104113241509
10.1056/nejm199104113241509 · External reference
10.1056/nejm198801143180202
10.1056/nejm198801143180202 · External reference
10.1056/nejm199112053252303
10.1056/nejm199112053252303 · External reference
10.1056/nejm199104113241501
10.1056/nejm199104113241501 · External reference
10.1056/nejm198905253202105
10.1056/nejm198905253202105 · External reference
10.1097/00007890-199403270-00019
10.1097/00007890-199403270-00019 · External reference
Impact of high‐dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high‐risk renal transplant recipients.
10.1681/asn.v72325 · 1996 · External reference
Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients.
1993 · External reference
Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.
10.1097/00007890-199712270-00036 · 1997 · External reference
Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post‐kidney transplant patients.
10.1111/j.1399-0012.1997.tb01057.x · 1997 · External reference
10.1056/nejm198604173141602
10.1056/nejm198604173141602 · External reference
10.1038/sj.bmt.1700649
10.1038/sj.bmt.1700649 · External reference
10.1056/nejm198710223171703
10.1056/nejm198710223171703 · External reference
10.1001/archsurg.1994.01420280121016
10.1001/archsurg.1994.01420280121016 · External reference
10.1097/00007890-199410150-00005
10.1097/00007890-199410150-00005 · External reference
10.1086/516139
10.1086/516139 · External reference
Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.
1993 · External reference
10.1111/j.1432-2277.1997.tb00725.x
10.1111/j.1432-2277.1997.tb00725.x · External reference
10.1016/s0140-6736(95)92110-9
10.1016/s0140-6736(95)92110-9 · External reference
10.1002/jmv.1890400103
10.1002/jmv.1890400103 · External reference
10.1097/00007890-199712150-00022
10.1097/00007890-199712150-00022 · External reference
10.1016/s0140-6736(97)05535-9
10.1016/s0140-6736(97)05535-9 · External reference
10.7326/0003-4819-119-10-199311150-00004
10.7326/0003-4819-119-10-199311150-00004 · External reference
10.1086/516095
10.1086/516095 · External reference
A randomized double‐blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient.
1991 · External reference
10.1056/nejm199204303261803
10.1056/nejm199204303261803 · External reference
10.1164/ajrccm.150.1.8025741
10.1164/ajrccm.150.1.8025741 · External reference
10.1097/00007890-199504270-00012
10.1097/00007890-199504270-00012 · External reference
10.1093/infdis/165.3.548
10.1093/infdis/165.3.548 · External reference
10.1001/archsurg.1995.01430110075014
10.1001/archsurg.1995.01430110075014 · External reference
10.1097/00007890-199812270-00036
10.1097/00007890-199812270-00036 · External reference
10.1097/00007890-198908000-00016
10.1097/00007890-198908000-00016 · External reference
10.1097/00007890-199001000-00015
10.1097/00007890-199001000-00015 · External reference
Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
10.1111/j.1399-0012.1996.tb00743.x · 1996 · External reference
10.7326/0003-4819-120-5-199403010-00004
10.7326/0003-4819-120-5-199403010-00004 · External reference
10.1097/00007890-199606150-00022
10.1097/00007890-199606150-00022 · External reference
10.1097/00007890-199910270-00011
10.1097/00007890-199910270-00011 · External reference
10.1128/aac.39.7.1643
10.1128/aac.39.7.1643 · External reference
10.1111/j.1432-2277.1996.tb00886.x
10.1111/j.1432-2277.1996.tb00886.x · External reference
10.1097/00007890-199803150-00026
10.1097/00007890-199803150-00026 · External reference
10.1097/00007890-199307000-00019
10.1097/00007890-199307000-00019 · External reference
10.1093/infdis/171.4.1006
10.1093/infdis/171.4.1006 · External reference
10.1093/clinids/24.5.824
10.1093/clinids/24.5.824 · External reference
10.1097/00007890-199712270-00016
10.1097/00007890-199712270-00016 · External reference
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes.
10.1128/jcm.30.11.2822-2825.1992 · 1992 · External reference
10.1099/0022-1317-73-2-437
10.1099/0022-1317-73-2-437 · External reference
Monitoring for cytomegalovirus after organ transplantation: a clinical perspective.
1993 · External reference
10.1016/0732-8893(95)00248-0
10.1016/0732-8893(95)00248-0 · External reference
10.1093/infdis/164.2.265
10.1093/infdis/164.2.265 · External reference
10.1097/00007890-199208000-00001
10.1097/00007890-199208000-00001 · External reference
10.1002/(sici)1096-9071(199711)53:3<189::aid-jmv2>3.0.co;2-4
10.1002/(sici)1096-9071(199711)53:3<189::aid-jmv2>3.0.co;2-4 · External reference
Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.
10.1681/asn.v891448 · 1997 · External reference
Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
10.1111/j.1399-0012.1997.tb00821.x · 1997 · External reference
10.1097/00007890-199303000-00017
10.1097/00007890-199303000-00017 · External reference
10.1136/thx.50.1.9
10.1136/thx.50.1.9 · External reference
10.1097/00007890-198912000-00019
10.1097/00007890-198912000-00019 · External reference
10.1002/jmv.1890250208
10.1002/jmv.1890250208 · External reference
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.
10.1128/jcm.30.5.1232-1237.1992 · External reference
10.1038/sj.bmt.1701354
10.1038/sj.bmt.1701354 · External reference
10.1093/infdis/164.3.488
10.1093/infdis/164.3.488 · External reference
10.1097/00007890-199603150-00014
10.1097/00007890-199603150-00014 · External reference
10.1097/00007890-199307000-00020
10.1097/00007890-199307000-00020 · External reference
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients.
10.1128/jcm.30.7.1876-1878.1992 · 1992 · External reference
10.1097/00007890-199503270-00008
10.1097/00007890-199503270-00008 · External reference
10.1001/archsurg.1989.01410120093018
10.1001/archsurg.1989.01410120093018 · External reference
10.1001/archsurg.1993.01420140042007
10.1001/archsurg.1993.01420140042007 · External reference
Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation.
1995 · External reference
10.1093/infdis/164.5.835
10.1093/infdis/164.5.835 · External reference
10.1002/jmv.1890440402
10.1002/jmv.1890440402 · External reference
10.1097/00007890-199304000-00031
10.1097/00007890-199304000-00031 · External reference
10.1093/infdis/168.2.332
10.1093/infdis/168.2.332 · External reference
10.1093/infdis/166.6.1228
10.1093/infdis/166.6.1228 · External reference
10.1097/00007890-199107000-00034
10.1097/00007890-199107000-00034 · External reference
10.1097/00007890-199702150-00026
10.1097/00007890-199702150-00026 · External reference
10.1097/00007890-199705270-00031
10.1097/00007890-199705270-00031 · External reference
10.1097/00007890-199808150-00008
10.1097/00007890-199808150-00008 · External reference
10.1093/infdis/163.4.716
10.1093/infdis/163.4.716 · External reference
10.1056/nejm198902023200505
10.1056/nejm198902023200505 · External reference
10.1093/infdis/168.2.332
10.1093/infdis/168.2.332 · External reference
10.1038/358160a0
10.1038/358160a0 · External reference
Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance.
1991 · External reference
10.1093/infdis/172.1.239
10.1093/infdis/172.1.239 · External reference
10.1093/infdis/171.3.576
10.1093/infdis/171.3.576 · External reference
10.1128/aac.37.1.19
10.1128/aac.37.1.19 · External reference
10.1093/clinids/12.supplement_7.s849
10.1093/clinids/12.supplement_7.s849 · External reference
10.1093/clinids/10.supplement_3.s495
10.1093/clinids/10.supplement_3.s495 · External reference
10.1097/00007890-199101000-00015
10.1097/00007890-199101000-00015 · External reference
Ganciclovir therapy for viral disease in liver transplant recipients.
1991 · External reference
Gastrointestinal cytomegalovirus infection in heart and heart–lung transplant recipients.
10.1001/archinte.1989.00390090127025 · 1989 · External reference
10.1001/archsurg.1991.01410260092013
10.1001/archsurg.1991.01410260092013 · External reference
10.1097/00007890-198808000-00008
10.1097/00007890-198808000-00008 · External reference
Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
10.1001/jama.1987.03390220080025 · 1987 · External reference
10.1093/infdis/164.6.1045
10.1093/infdis/164.6.1045 · External reference
10.7326/0003-4819-112-7-505
10.7326/0003-4819-112-7-505 · External reference
10.2165/00003495-199141010-00009
10.2165/00003495-199141010-00009 · External reference
10.1038/sj.bmt.1700910
10.1038/sj.bmt.1700910 · External reference
10.1093/infdis/171.4.788
10.1093/infdis/171.4.788 · External reference
10.1093/clinids/12.supplement_7.s839
10.1093/clinids/12.supplement_7.s839 · External reference
Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients – A meta‐analysis.
10.1111/j.1399-0012.1994.tb00935.x · External reference
10.1128/aac.33.11.1975
10.1128/aac.33.11.1975 · External reference
10.7326/0003-4819-109-10-783
10.7326/0003-4819-109-10-783 · External reference
10.1093/clinids/14.4.831
10.1093/clinids/14.4.831 · External reference
10.1097/00007890-199107000-00033
10.1097/00007890-199107000-00033 · External reference
Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
1989 · External reference
10.1001/archopht.1996.01100130021004
10.1001/archopht.1996.01100130021004 · External reference
10.1128/aac.34.2.373
10.1128/aac.34.2.373 · External reference
10.1097/00007890-199608150-00013
10.1097/00007890-199608150-00013 · External reference
